Information Provided By:
Fly News Breaks for November 6, 2015
AXGN
Nov 6, 2015 | 08:46 EDT
JMP Securities raised its price target on AxoGen as the firm thinks the company reported very strong Q3 results. The firm continues to believe that the company's Avance product can become the new standard of care in nerve repair. It keeps an Outperform rating.
News For AXGN From the Last 2 Days
There are no results for your query AXGN